245 related articles for article (PubMed ID: 26674707)
21. Serotonin Transporter Gene Polymorphisms and Selective Serotonin Reuptake Inhibitor Tolerability: Review of Pharmacogenetic Evidence.
Zhu J; Klein-Fedyshin M; Stevenson JM
Pharmacotherapy; 2017 Sep; 37(9):1089-1104. PubMed ID: 28654193
[TBL] [Abstract][Full Text] [Related]
22. Association between the loudness dependence of auditory evoked potential, serotonergic neurotransmission and treatment outcome in patients with depression.
Ip CT; Ganz M; Ozenne B; Olbrich S; Beliveau V; Dam VH; Köhler-Forsberg K; Jørgensen MB; Frøkjær VG; Knudsen GM
Eur Neuropsychopharmacol; 2023 May; 70():32-44. PubMed ID: 36863106
[TBL] [Abstract][Full Text] [Related]
23. Elevated brain serotonin turnover in patients with depression: effect of genotype and therapy.
Barton DA; Esler MD; Dawood T; Lambert EA; Haikerwal D; Brenchley C; Socratous F; Hastings J; Guo L; Wiesner G; Kaye DM; Bayles R; Schlaich MP; Lambert GW
Arch Gen Psychiatry; 2008 Jan; 65(1):38-46. PubMed ID: 18180427
[TBL] [Abstract][Full Text] [Related]
24. SSRI/SNRI -induced Hyponatremia: A Case Series of 26 Patients in a Single Institution from 2018 to 2020.
Zhao Z; Zhao F; Jin P; Hu X; Tian C; Liu D; Zhang Y
Psychiatr Q; 2023 Jun; 94(2):113-125. PubMed ID: 36913163
[TBL] [Abstract][Full Text] [Related]
25. Association between a functional serotonin transporter promoter polymorphism and citalopram treatment in adult outpatients with major depression.
Hu XZ; Rush AJ; Charney D; Wilson AF; Sorant AJ; Papanicolaou GJ; Fava M; Trivedi MH; Wisniewski SR; Laje G; Paddock S; McMahon FJ; Manji H; Lipsky RH
Arch Gen Psychiatry; 2007 Jul; 64(7):783-92. PubMed ID: 17606812
[TBL] [Abstract][Full Text] [Related]
26. Does pretreatment testing for serotonin transporter polymorphisms lead to earlier effects of drug treatment in patients with major depression? A decision-analytic model.
Smits KM; Smits LJ; Schouten JS; Peeters FP; Prins MH
Clin Ther; 2007 Apr; 29(4):691-702. PubMed ID: 17617292
[TBL] [Abstract][Full Text] [Related]
27. Serotonin Transporter Gene Promoter Hypomethylation as a Predictor of Antidepressant Treatment Response in Major Depression: A Replication Study.
Schiele MA; Zwanzger P; Schwarte K; Arolt V; Baune BT; Domschke K
Int J Neuropsychopharmacol; 2021 Mar; 24(3):191-199. PubMed ID: 33125470
[TBL] [Abstract][Full Text] [Related]
28. Healthcare resource use and cost associated with timing of pharmacological treatment for major depressive disorder in the United States: a real-world study.
McIntyre RS; Prieto R; Schepman P; Yeh YC; Boucher M; Shelbaya A; Chambers R; Gao X; Pappadopulos E
Curr Med Res Opin; 2019 Dec; 35(12):2169-2177. PubMed ID: 31370711
[No Abstract] [Full Text] [Related]
29. [Prediction of antidepressant response to milnacipran and fluvoxamine using pharmacogenetical methods].
Higuchi H
Nihon Shinkei Seishin Yakurigaku Zasshi; 2010 Apr; 30(2):71-6. PubMed ID: 20491280
[TBL] [Abstract][Full Text] [Related]
30. Detailed analysis of the serotonin transporter gene (SLC6A4) shows no association with bipolar disorder in the Northern Swedish population.
Alaerts M; Ceulemans S; Forero D; Moens LN; De Zutter S; Heyrman L; Lenaerts AS; Norrback KF; Goossens D; De Rijk P; Nilsson LG; Adolfsson R; Del-Favero J
Am J Med Genet B Neuropsychiatr Genet; 2009 Jun; 150B(4):585-92. PubMed ID: 18792946
[TBL] [Abstract][Full Text] [Related]
31. Selective Serotonin Reuptake Inhibitors and Serotonin-Norepinephrine Reuptake Inhibitors Are Not Associated With Bleeding or Transfusion in Cardiac Surgical Patients.
Smith MM; Smith BB; Lahr BD; Nuttall GA; Mauermann WJ; Weister TJ; Dearani JA; Barbara DW
Anesth Analg; 2018 Jun; 126(6):1859-1866. PubMed ID: 29210786
[TBL] [Abstract][Full Text] [Related]
32. Effects of the serotonin transporter gene promoter polymorphism on mirtazapine and paroxetine efficacy and adverse events in geriatric major depression.
Murphy GM; Hollander SB; Rodrigues HE; Kremer C; Schatzberg AF
Arch Gen Psychiatry; 2004 Nov; 61(11):1163-9. PubMed ID: 15520364
[TBL] [Abstract][Full Text] [Related]
33. Serotonin transporter genotype and function in relation to antidepressant response in Koreans.
Myung W; Lim SW; Kim S; Kim H; Chung JW; Seo MY; Kim JW; Carroll BJ; Kim DK
Psychopharmacology (Berl); 2013 Jan; 225(2):283-90. PubMed ID: 22885912
[TBL] [Abstract][Full Text] [Related]
34. Influence of antidepressant treatment on SLC6A4 methylation in Korean patients with major depression.
Moon YK; Kim H; Kim S; Lim SW; Kim DK
Am J Med Genet B Neuropsychiatr Genet; 2023 Jan; 192(1-2):28-37. PubMed ID: 36094099
[TBL] [Abstract][Full Text] [Related]
35. Molecular imaging of the serotonin transporter availability and occupancy by antidepressant treatment in late-life depression.
Smith GS; Kuwabara H; Gould NF; Nassery N; Savonenko A; Joo JH; Bigos KL; Kraut M; Brasic J; Holt DP; Hall AW; Mathews WB; Dannals RF; Nandi A; Workman CI
Neuropharmacology; 2021 Aug; 194():108447. PubMed ID: 33450276
[TBL] [Abstract][Full Text] [Related]
36. Serotonin-norepinephrine reuptake inhibitor and selective serotonin reuptake inhibitor use and risk of fractures: a new-user cohort study among US adults aged 50 years and older.
Lanteigne A; Sheu YH; Stürmer T; Pate V; Azrael D; Swanson SA; Miller M
CNS Drugs; 2015 Mar; 29(3):245-52. PubMed ID: 25708711
[TBL] [Abstract][Full Text] [Related]
37. Selective Serotonin Reuptake Inhibitors and Serotonin and Noradrenaline Reuptake Inhibitors Improve Cognitive Function in Partial Responders Depressed Patients: Results from a Prospective Observational Cohort Study.
Castellano S; Ventimiglia A; Salomone S; Ventimiglia A; De Vivo S; Signorelli MS; Bellelli E; Santagati M; Cantarella RA; Fazio E; Aguglia E; Drago F; Di Nuovo S; Caraci F
CNS Neurol Disord Drug Targets; 2016; 15(10):1290-1298. PubMed ID: 27712575
[TBL] [Abstract][Full Text] [Related]
38. Antidepressant treatment increased serum miR-183 and miR-212 levels in patients with major depressive disorder.
Lin CC; Tsai MC; Lee CT; Sun MH; Huang TL
Psychiatry Res; 2018 Dec; 270():232-237. PubMed ID: 30269040
[TBL] [Abstract][Full Text] [Related]
39. Sequence variations of ABCB1, SLC6A2, SLC6A3, SLC6A4, CREB1, CRHR1 and NTRK2: association with major depression and antidepressant response in Mexican-Americans.
Dong C; Wong ML; Licinio J
Mol Psychiatry; 2009 Dec; 14(12):1105-18. PubMed ID: 19844206
[TBL] [Abstract][Full Text] [Related]
40. Female sexual dysfunction in patients with major depressive disorder (MDD) treated with selective serotonin reuptake inhibitor (SSRI) and its association with serotonin 2A-1438 G/A single nucleotide polymorphisms.
Masiran R; Sidi H; Mohamed Z; Mohd Nazree NE; Nik Jaafar NR; Midin M; Das S; Mohamed Saini S
J Sex Med; 2014 Apr; 11(4):1047-1055. PubMed ID: 24533444
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
